Quantification of Prostaglandin E2 Concentration in Interstitial Fluid from the Hypothalamic Region of Free-moving Mice
Authors:
- Yoshinobu NakamuraYNYoshinobu Nakamura
- Takatoshi SakaguchiTSTakatoshi Sakaguchi
- Ikumi TamaiITIkumi Tamai
- Takeo NakanishiTakeo Nakanishi
- 1 January 2019
- journal article
- research article
- Published by Bio-Protocol, LLC in Bio-Protocol
- Vol. 9 (15)
Abstract
Prostaglandin E2 (PGE2) is a well-established chemical mediator for the generation of the fever at the hypothalamus of the brain. PGE2 mediates fever generation via PGE receptor 3 (i.e., EP3) on neurons in the preoptic area. The role of PGE2 has been analyzed by measuring PGE2 concentration in cerebrospinal fluid (Ccsf); however, local PGE2 concentration at the hypothalamus may not necessarily be consistent with Ccsf. In this protocol, we introduce our method to measure directly the alteration in PGE2 concentration in interstitial fluid in the hypothalamus (Cisf) of awake (free-moving) mice using a microdialysis technique. Male mice (c57BL/6J) were anesthetized and fixed in the stereotaxic instrument, and a microdialysis probe was inserted into the hypothalamus through a guide cannula. On the fifth postoperative day, Cisf was monitored in free-moving mice that were intraperitoneally (i.p.) injected with lipopolysaccharide (LPS). PGE2 and other eicosanoids recovered in Krebs-Ringer phosphate buffer and defused through a microdialysis probe were extracted into ethyl acetate/formic acid and then quantified with LC-MS/MS. Our method is useful to understand the role of key regulators of prostaglandin concentration such as those of transporters, which have been unappreciated in inflammation-based brain diseases.Keywords
This publication has 17 references indexed in Scilit:
- Apolipoprotein E does not cross the blood-cerebrospinal fluid barrier, as revealed by an improved technique for sampling CSF from miceAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2012
- Role of the blood–cerebrospinal fluid barrier transporter as a cerebral clearance system for prostaglandin E2produced in the brainJournal of Neurochemistry, 2012
- Failure of Postnatal Ductus Arteriosus Closure in Prostaglandin Transporter–Deficient MiceCirculation, 2010
- Expression and localization of prostaglandin transporter in Alzheimer disease brains and age-matched controlsJournal of Neuroimmunology, 2008
- An improved LC–MS/MS method for the quantification of prostaglandins E2 and D2 production in biological fluidsAnalytical Biochemistry, 2008
- Effects of LPS stimulation on the expression of prostaglandin carriers in the cells of the blood-brain and blood-cerebrospinal fluid barriersJournal of Applied Physiology, 2006
- LC–MS/MS-analysis of prostaglandin E2 and D2 in microdialysis samples of ratsJournal of Chromatography B, 2005
- Hypothalamic prostaglandin E2 during lipopolysaccharide-induced fever in guinea pigsBrain Research Bulletin, 1996
- Changes in hypothalamic prostaglandin E2 may predict the occurrence of sleep or wakefulness as assessed by parallel EEG and microdialysis in the ratBrain Research, 1995
- Identification and Characterization of a Prostaglandin TransporterScience, 1995